Larson RA - Articles from Medline

Last articles by author Larson RA

277 articles found

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
02/07/2008
Low-Dose Interleukin-2 Immunotherapy Does Not Improve Outcome of Patients Age 60 Years and Older With Acute Myeloid Leukemia in First Complete Remission: Cancer and Leukemia Group B Study 9720.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
19/06/2008
Patients With Acute Myeloid Leukemia and RAS Mutations Benefit Most From Postremission High-Dose Cytarabine: A Cancer and Leukemia Group B Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
19/06/2008
Wilms Tumor 1 Gene Mutations Independently Predict Poor Outcome in Adults With Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study.
Blood
27/05/2008
What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of children's cancer group and cancer and leukemia group b studies.
Leukemia & lymphoma
03/05/2008
Feasibility of administering oblimersen (G3139; Genasense) with imatinib mesylate in patients with imatinib resistant chronic myeloid leukemia - Cancer and leukemia group B study 10107.
The New England journal of medicine
10/05/2008
MicroRNA expression in cytogenetically normal acute myeloid leukemia.
Blood
23/04/2008
MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility.
Investigational New Drugs
22/04/2008
A phase I and pharmacokinetic study of XK469R (NSC 698215), a quinoxaline phenoxypropionic acid derivative, in patients with refractory acute leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K
27/06/2008
Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib.
Blood
02/07/2008
High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study.

National Library of Medicine

Create email alert

Send to a friend

Doctors UK Consultants UK

Articles from other specialties:

Forensic and Legal Medicine, Paediatrics, Psychiatry, Odontology, Pulmonology, Clinical Neurophysiology, Gynaecology - Obstetrics, Traumatology - Orthopaedics, Nephrology, Neurosurgery, Thoracic Surgery, Occupational Medicine, Cardiovascular Surgery